Xilio Therapeutics, Inc. (XLO) Earnings
|
Expand Research on XLO
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -68.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.58 | N/A | N/A | $7.27M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/12/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A |
